LendingTree (TREE) 10-Q 1 May 24 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	Apr. 26, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-34063
Entity Registrant Name	LendingTree, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-2414818
Entity Address, Address Line One	1415 Vantage Park Dr.
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Charlotte
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28203
City Area Code	704
Local Phone Number	541-5351
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	TREE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		13,224,515
Entity Central Index Key	0001434621
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1

CONSOLIDATED BALANCE SHEETS (Un

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
ASSETS:
Cash and cash equivalents	$ 230,745	$ 112,051
Restricted cash and cash equivalents	16	5
Accounts receivable (net of allowance of $2,026 and $2,222, respectively)	63,318	54,954
Prepaid and other current assets	31,604	29,472
Total current assets	325,683	196,482
Property and equipment (net of accumulated depreciation of $36,702 and $36,827, respectively)	48,300	50,481
Operating lease right-of-use assets	56,094	57,222
Goodwill	381,539	381,539
Intangible assets, net	49,132	50,620
Equity investments	60,076	60,076
Other non-current assets	5,871	6,339
Total assets	926,695	802,759
LIABILITIES:
Current portion of long-term debt	14,899	3,125
Accounts payable, trade	3,097	1,960
Accrued expenses and other current liabilities	69,717	70,544
Total current liabilities	87,713	75,629
Long-term debt	631,333	525,617
Operating lease liabilities	73,637	75,023
Deferred income tax liabilities	2,219	2,091
Other non-current liabilities	278	267
Total liabilities	795,180	678,627
Commitments and contingencies (Note 13)
SHAREHOLDERS' EQUITY:
Preferred stock $0.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock $0.01 par value; 50,000,000 shares authorized; 16,577,446 and 16,396,911 shares issued, respectively, and 13,221,980 and 13,041,445 shares outstanding, respectively	166	164
Additional paid-in capital	1,234,214	1,227,849
Accumulated deficit	(836,687)	(837,703)
Treasury stock; 3,355,466 and 3,355,466 shares, respectively	(266,178)	(266,178)
Total shareholders' equity	131,515	124,132
Total liabilities and shareholders' equity	$ 926,695	$ 802,759

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit loss	$ 2,026	$ 2,222
Accumulated depreciation	$ 36,702	$ 36,827
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	16,577,446	16,396,911
Common stock, shares outstanding	13,221,980	13,041,445
Treasury stock, shares	3,355,466	3,355,466

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 167,768	$ 200,508
Costs and expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)	8,545	13,760
Selling and marketing expense	108,176	137,111
General and administrative expense	25,796	36,683
Product development	11,857	14,655
Depreciation	4,667	4,795
Amortization of intangibles	1,489	2,049
Restructuring and severance	23	4,454
Litigation settlements and contingencies	36	12
Total costs and expenses	160,589	213,519
Operating income (loss)	7,179	(13,011)
Other income (expense), net:
Interest (expense) income, net	(6,638)	25,029
Other income	1,034	1,834
Income before income taxes	1,575	13,852
Income tax expense	(559)	(395)
Net income	1,016	13,457
Comprehensive income	$ 1,016	$ 13,457
Weighted average shares outstanding:
Basic (in shares)	13,100	12,846
Diluted (in shares)	13,276	12,935
Net income per share:
Basic (in dollars per share)	$ 0.08	$ 1.05
Diluted (in dollars per share)	$ 0.08	$ 1.04

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock
Beginning balance at Dec. 31, 2022	$ 207,940	$ 162	$ 1,189,255	$ (715,299)	$ (266,178)
Beginning balance, common (in shares) at Dec. 31, 2022		16,167,000
Beginning balance, treasury (in shares) at Dec. 31, 2022					3,355,000
Increase (Decrease) in Stockholders' Equity
Net income	13,457			13,457
Comprehensive income (loss)	13,457			13,457
Non-cash compensation	11,274		11,274
Issuance of common stock for stock options, restricted stock awards and restricted stock units, net of withholding taxes	(1,693)	$ 1	(1,694)
Issuance of common stock for stock options, restricted stock awards and restricted stock units, net of withholding taxes and cancellations (in shares)		98,000
Other	1		1
Ending balance at Mar. 31, 2023	230,979	$ 163	1,198,836	(701,842)	$ (266,178)
Ending balance, common (in shares) at Mar. 31, 2023		16,265,000
Ending balance, treasury (in shares) at Mar. 31, 2023					3,355,000
Beginning balance at Dec. 31, 2023	$ 124,132	$ 164	1,227,849	(837,703)	$ (266,178)
Beginning balance, common (in shares) at Dec. 31, 2023	13,041,445	16,397,000
Beginning balance, treasury (in shares) at Dec. 31, 2023	3,355,466				3,355,000
Increase (Decrease) in Stockholders' Equity
Net income	$ 1,016			1,016
Comprehensive income (loss)	1,016			1,016
Non-cash compensation	7,789		7,789
Issuance of common stock for stock options, restricted stock awards and restricted stock units, net of withholding taxes	(1,422)	$ 2	(1,424)
Issuance of common stock for stock options, restricted stock awards and restricted stock units, net of withholding taxes and cancellations (in shares)		180,000
Ending balance at Mar. 31, 2024	$ 131,515	$ 166	$ 1,234,214	$ (836,687)	$ (266,178)
Ending balance, common (in shares) at Mar. 31, 2024	13,221,980	16,577,000
Ending balance, treasury (in shares) at Mar. 31, 2024	3,355,466				3,355,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 1,016	$ 13,457
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on impairments and disposal of assets	368	5,027
Amortization of intangibles	1,489	2,049
Depreciation	4,667	4,795
Non-cash compensation expense	7,789	11,274
Deferred income taxes	128	360
Bad debt expense	(129)	963
Amortization of debt issuance costs	612	1,959
Write-off of previously-capitalized debt issuance costs	0	2,373
Amortization of debt discount	6	0
Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities	(1,007)	(877)
Gain on settlement of convertible debt	0	(34,308)
Changes in current assets and liabilities:
Accounts receivable	(8,235)	(211)
Prepaid and other current assets	(2,034)	(1,882)
Accounts payable, accrued expenses and other current liabilities	797	8,559
Income taxes receivable	86	42
Other, net	155	(424)
Net cash provided by operating activities	5,708	13,156
Cash flows from investing activities:
Capital expenditures	(2,746)	(2,452)
Net cash used in investing activities	(2,746)	(2,452)
Cash flows from financing activities:
Proceeds from term loan	125,000	0
Repayment of term loan	(625)	(625)
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options	(1,422)	(1,693)
Repurchase of 0.50% Convertible Senior Notes	0	(156,294)
Payment of debt issuance costs	(4,085)	(953)
Payment of original issue discount	(3,125)	0
Net cash provided by (used in) financing activities	115,743	(159,565)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	118,705	(148,861)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	112,056	298,969
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 230,761	$ 150,108

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical)	Mar. 31, 2024 Rate
2025 Convertible Notes
Stated interest rate	0.50%

ORGANIZATION

ORGANIZATION	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	ORGANIZATION Company Overview LendingTree, Inc. is the parent of LT Intermediate Company, LLC, which holds all of the outstanding ownership interests of LendingTree, LLC, and LendingTree, LLC owns several companies (collectively, “LendingTree” or the “Company”). LendingTree operates what it believes to be the leading online consumer platform that connects consumers with the choices they need to be confident in their financial decisions. The Company offers consumers tools and resources, including free credit scores, that facilitate comparison-shopping for mortgage loans, home equity loans and lines of credit, auto loans, credit cards, deposit accounts, personal loans, student loans, small business loans, insurance quotes, sales of insurance policies, and other related offerings. The Company primarily seeks to match in-market consumers with multiple providers on its marketplace who can provide them with competing quotes for loans, deposit products, insurance, or other related offerings they are seeking. The Company also serves as a valued partner to lenders and other providers seeking an efficient, scalable, and flexible source of customer acquisition with directly measurable benefits, by matching the consumer inquiries it generates with these providers. The consolidated financial statements include the accounts of LendingTree and all its wholly-owned entities. Intercompany transactions and accounts have been eliminated. Basis of Presentation

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Accounting Estimates Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. The Company considered the impact of the current economic conditions, including interest rates and inflation on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional information is obtained. If economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity. Certain Risks and Concentrations LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and fraud. Financial instruments, which potentially subject the Company to concentration of credit risk at March 31, 2024, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which in the event of non-payment, would be applied against any accounts receivable outstanding. Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace. Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service. Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States. Litigation Settlements and Contingencies Litigation settlements and contingencies consists of expenses related to actual or anticipated litigation settlements. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2023-07 which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. This ASU is effective for annual periods beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, including adoption in interim periods. An entity should adopt the guidance as of the beginning of the earliest period presented. The Company is evaluating the impact this ASU will have on its consolidated financial statements and whether to early adopt. In December 2023, the FASB issued ASU 2023-09 which expands annual disclosure requirements for income taxes, primarily through disclosure about disaggregated information about an entity's effective tax rate reconciliation and information on income taxes paid. This ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The guidance will be applied on a prospective basis with the option to adopt the guidance retrospectively. The Company is evaluating the impact this ASU will have on its consolidated financial statements and whether to early adopt.

REVENUE

REVENUE	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Revenue is as follows (in thousands) : Three Months Ended 2024 2023 Home $ 30,443 $ 43,675 Personal loans 20,127 23,599 Other Consumer 31,324 56,110 Total Consumer 51,451 79,709 Insurance 85,872 77,082 Other 2 42 Total revenue $ 167,768 $ 200,508 The Company derives its revenue primarily from match fees and closing fees. Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied and promised services have transferred to the customer. The Company's services are generally transferred to the customer at a point in time. Revenue from Home products is primarily generated from upfront match fees paid by mortgage Network Partners that receive a loan request, and in some cases upfront fees for clicks or call transfers. Match fees and upfront fees for clicks and call transfers are earned through the delivery of loan requests that originated through the Company's websites or affiliates. The Company recognizes revenue at the time a loan request is delivered to the customer, provided that no significant obligations remain. The Company's contractual right to the match fee consideration is contemporaneous with the satisfaction of the performance obligation to deliver a loan request to the customer. Revenue from Consumer products is generated by match and other upfront fees for clicks or call transfers, as well as from closing fees, approval fees and upfront service and subscription fees. Closing fees are derived from lenders on certain auto loans, business loans, personal loans, and student loans when the lender funds a loan with the consumer. Approval fees are derived from credit card issuers when the credit card consumer receives card approval from the credit card issuer. Upfront service fees and subscription fees were derived from consumers in the Company's credit services product. Upfront fees paid by consumers were recognized as revenue over the estimated time the consumer was expected to remain a customer and receive services. Subscription fees were recognized over the period a consumer was receiving services. As of the second quarter of 2023, the Company discontinued providing its credit services product to consumers and no longer receives upfront fees and subscription fees. The Company recognizes revenue on closing fees and approval fees at the point when a loan request or a credit card consumer is delivered to the customer. The Company's contractual right to closing fees and approval fees is not contemporaneous with the satisfaction of the performance obligation to deliver a loan request or a credit card consumer to the customer. As such, the Company records a contract asset at each reporting period-end related to the estimated variable consideration on closing fees and approval fees for which the Company has satisfied the related performance obligation but are still pending the loan closing or credit card approval before the Company has a contractual right to payment. This estimate is based on the Company's historical closing rates and historical time between when a consumer request for a loan or credit card is delivered to the lender or card issuer and when the loan is closed by the lender or approved by the card issuer. Revenue from the Company's Insurance products is primarily generated from upfront match fees and upfront fees for website clicks or fees for calls. Match fees and upfront fees for clicks and call transfers are earned through the delivery of consumer requests that originated through the Company's websites or affiliates. The Company recognizes revenue at the time a consumer request is delivered to the customer, provided that no significant obligations remain. The Company's contractual right to the match fee consideration is contemporaneous with the satisfaction of the performance obligation to deliver a consumer request to the customer. The contract asset recorded within prepaid and other current assets on the consolidated balance sheets related to estimated variable consideration was $15.1 million and $13.7 million at March 31, 2024 and December 31, 2023, respectively. As the contract liability was in the Ovation business that was closed during 2023, there was no contract liability at December 31, 2023. During the first three months of 2023, the Company recognized revenue of $0.8 million that was included in the contract liability balance at December 31, 2022. Revenue recognized in any reporting period includes estimated variable consideration for which the Company has satisfied the related performance obligations but are still pending the occurrence or non-occurrence of a future event outside the Company's control (such as lenders providing loans to consumers or credit card approvals of consumers) before the Company has a contractual right to payment. The Company recognizes increases or decreases to such revenue from prior periods. This increase was $0.3 million in the first quarter of 2024 and $0.2 million in the first quarter of 2023.

CASH AND RESTRICTED CASH

CASH AND RESTRICTED CASH	3 Months Ended
	Mar. 31, 2024
Cash and Cash Equivalents [Abstract]
CASH AND RESTRICTED CASH	CASH AND RESTRICTED CASH Total cash, cash equivalents, restricted cash and restricted cash equivalents consist of the following (in thousands) : March 31, December 31, Cash and cash equivalents $ 230,745 $ 112,051 Restricted cash and cash equivalents 16 5 Total cash, cash equivalents, restricted cash and restricted cash equivalents $ 230,761 $ 112,056

ALLOWANCE FOR DOUBTFUL ACCOUNTS

ALLOWANCE FOR DOUBTFUL ACCOUNTS	3 Months Ended
	Mar. 31, 2024
Credit Loss [Abstract]
ALLOWANCE FOR DOUBTFUL ACCOUNTS	ALLOWANCE FOR DOUBTFUL ACCOUNTS Accounts receivable are stated at amounts due from customers, net of an allowance for doubtful accounts. The Company determines its allowance for doubtful accounts by considering a number of factors, including the length of time accounts receivable are past due, previous loss history, current and expected economic conditions and the specific customer's current and expected ability to pay its obligation. Accounts receivable are considered past due when they are outstanding longer than the contractual payment terms. Accounts receivable are written off when management deems them uncollectible. A reconciliation of the beginning and ending balances of the allowance for doubtful accounts is as follows (in thousands) : Three Months Ended 2024 2023 Balance, beginning of the period $ 2,222 $ 2,317 Charges to earnings (129) 963 Write-off of uncollectible accounts receivable (67) (963) Assets held for sale — 371 Balance, end of the period $ 2,026 $ 2,688

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS The balance of goodwill, net and intangible assets, net is as follows (in thousands) : March 31, December 31, Goodwill $ 903,227 $ 903,227 Accumulated impairment losses (521,688) (521,688) Net goodwill $ 381,539 $ 381,539 Intangible assets with indefinite lives $ 10,142 $ 10,142 Intangible assets with definite lives, net 38,990 40,478 Total intangible assets, net $ 49,132 $ 50,620 Goodwill and Indefinite-Lived Intangible Assets The Company's goodwill at each of March 31, 2024 and December 31, 2023 consisted of $59.3 million associated with the Home segment, $166.1 million associated with the Consumer segment, and $156.1 million associated with the Insurance segment. During the third quarter of 2023, the Company concluded that a triggering event had occurred related to its goodwill and an interim quantitative impairment test was performed as of September 30, 2023. During the third quarter of 2023, the Company's market capitalization fell below its book value. Additionally, the Home reporting unit continued to struggle due to the effects of the significant increases in mortgage rates, low for-sale home inventories and the rise in home prices. The Insurance reporting unit continued to see pressure due to the consumer price inflation negatively impacting carrier underwriting. Upon completing a quantitative goodwill impairment test, the Company concluded that the carrying value of the Insurance reporting unit exceeded its fair value which resulted in a goodwill impairment charge of $38.6 million in the third quarter of 2023. The fair value of the Home and Consumer reporting units exceeded their carrying amounts, indicating no goodwill impairment. The Company will monitor the recovery of the Insurance reporting unit and the Home reporting unit and any changes in the timing of the recovery could cause an impairment to the Insurance or Home reporting unit. Intangible assets with indefinite lives relate to the Company's trademarks. Intangible Assets with Definite Lives Intangible assets with definite lives relate to the following (in thousands) : Cost Accumulated Net Customer lists 76,100 (37,110) 38,990 Balance at March 31, 2024 $ 76,100 $ (37,110) $ 38,990 Cost Accumulated Net Customer lists $ 76,100 $ (35,644) $ 40,456 Trademarks and tradenames 1,300 (1,278) 22 Balance at December 31, 2023 $ 77,400 $ (36,922) $ 40,478 Amortization of intangible assets with definite lives is computed on a straight-line basis and, based on balances as of March 31, 2024, future amortization is estimated to be as follows (in thousands) : Amortization Expense Remainder of current year $ 4,401 Year ending December 31, 2025 5,830 Year ending December 31, 2026 5,504 Year ending December 31, 2027 5,198 Year ending December 31, 2028 4,685 Thereafter 13,372 Total intangible assets with definite lives, net $ 38,990

EQUITY INVESTMENTS

EQUITY INVESTMENTS	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
EQUITY INVESTMENTS	EQUITY INVESTMENTS The equity investments do not have a readily determinable fair value and, upon acquisition, the Company elected the measurement alternative to value its investments. Accordingly, the equity investments will be carried at cost less impairment, if any, and subsequently measured to fair value upon observable price changes in an orderly transaction for the identical or similar investments. Additionally, if a qualitative assessment identifies impairment indicators, then the equity investments must be evaluated for impairment and written down to its fair value, if it is determined that the fair value is less than the carrying value. Any gains or losses are included within other income (expense) in the consolidated statement of operations and comprehensive income. In the third quarter of 2023, the Company determined there was an impairment indicator related to its Stash investment and performed a valuation of the investment. Based on the valuation, the Company determined the estimated fair value was below the carrying value of the investment and recorded an impairment charge of $113.1 million.

ACCRUED EXPENSES AND OTHER CURR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consist of the following (in thousands) : March 31, December 31, Accrued advertising expense $ 37,334 $ 27,859 Accrued compensation and benefits 8,072 15,091 Accrued professional fees 816 1,101 Customer deposits and escrows 7,113 7,732 Current lease liabilities 6,637 7,387 Other 9,745 11,374 Total accrued expenses and other current liabilities $ 69,717 $ 70,544

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
SHAREHOLDERS' EQUITY	SHAREHOLDERS' EQUITY Basic and diluted income per share was determined based on the following share data (in thousands) : Three Months Ended 2024 2023 Weighted average basic common shares 13,100 12,846 Effect of stock options 61 54 Effect of dilutive share awards 115 35 Weighted average diluted common shares 13,276 12,935 For the first quarter of 2024, the weighted average shares that were anti-dilutive, and therefore excluded from the calculation of diluted income per share, included options to purchase 1.0 million shares of common stock and 0.3 million restricted stock units. For the first quarter of 2023, the weighted average shares that were anti-dilutive, and therefore excluded from the calculation of diluted income per share, included options to purchase 1.0 million shares of common stock and 0.4 million restricted stock units. The convertible notes and the warrants issued by the Company could be converted into the Company’s common stock, subject to certain contingencies. Approximately 0.6 million shares related to the potentially dilutive shares of the Company's common stock associated with the 0.50% Convertible Senior Notes due July 15, 2025 were excluded from the calculation of diluted loss per share for the first quarter of 2024 because their inclusion would have been anti-dilutive. Approximately 1.2 million shares related to the potentially dilutive shares of the Company's common stock associated with the 0.50% Convertible Senior Notes due July 15, 2025 for the first quarter of 2023 were excluded from the calculation of diluted income per share for the first quarter of 2023 because their inclusion would have been anti-dilutive. Shares of the Company's stock associated with the warrants issued by the Company in 2020 were excluded from the calculation of diluted loss per share for the first quarter of 2024 and for the first quarter of 2023, as they were anti-dilutive since the strike price of the warrants was greater than the average market price of the Company's common stock during the relevant periods. Common Stock Repurchases The Company has a plan authorized for the repurchase of LendingTree's common stock. During the first quarter of 2024 and the first quarter of 2023, the Company did not purchase shares of its common stock. At March 31, 2024, approximately $96.7 million of the previous authorizations to repurchase common stock remain available.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION Non-cash compensation related to equity awards is included in the following line items in the accompanying consolidated statements of operations and comprehensive income (in thousands) : Three Months Ended 2024 2023 Cost of revenue $ 95 $ 214 Selling and marketing expense 1,024 1,744 General and administrative expense 5,333 7,343 Product development 1,337 1,902 Restructuring and severance — 71 Total non-cash compensation $ 7,789 $ 11,274 Stock Options A summary of changes in outstanding stock options is as follows: Number of Options Weighted Weighted Aggregate Intrinsic Value (a) (per option) (in years) (in thousands) Options outstanding at January 1, 2024 734,775 $ 150.74 Granted — — Exercised (54,103) 23.80 Forfeited — — Expired — — Options outstanding at March 31, 2024 680,672 160.83 3.74 $ 3,199 Options exercisable at March 31, 2024 590,523 $ 148.04 3.23 $ 3,199 (a) The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company's closing stock price of $42.34 on the last trading day of the quarter ended March 31, 2024 and the exercise price, multiplied by the number of shares covered by in-the-money options) that would have been received by the option holder had the option holder exercised these options on March 31, 2024. The intrinsic value changes based on the market value of the Company's common stock. Stock Options with Market Conditions A summary of changes in outstanding stock options with market conditions at target is as follows: Number of Options with Market Conditions Weighted Weighted Aggregate Intrinsic Value (a) (per option) (in years) (in thousands) Options outstanding at January 1, 2024 718,438 $ 229.02 Granted — — Exercised — — Forfeited — — Expired (19,126) 275.82 Options outstanding at March 31, 2024 699,312 227.74 4.39 $ — Options exercisable at March 31, 2024 481,669 $ 195.10 3.35 $ — (a) The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company's closing stock price of $42.34 on the last trading day of the quarter ended March 31, 2024 and the exercise price, multiplied by the number of shares covered by in-the-money options) that would have been received by the option holder had the option holder exercised these options on March 31, 2024. The intrinsic value changes based on the market value of the Company's common stock. As of March 31, 2024, a maximum of 363,464 shares may be earned for achieving superior performance up to 167% of the remaining unvested target number of shares. As of March 31, 2024, no additional performance-based nonqualified stock options with a market condition had been earned. Restricted Stock Units A summary of changes in outstanding nonvested restricted stock units (“RSUs”) is as follows: RSUs Number of Units Weighted Average Grant Date Fair Value (per unit) Nonvested at January 1, 2024 471,593 $ 66.42 Granted 363,765 39.93 Vested (194,992) 76.76 Forfeited (17,931) 55.31 Nonvested at March 31, 2024 622,435 $ 48.02 Restricted Stock Units with Market Conditions A summary of changes in outstanding nonvested RSUs with performance conditions is as follows: RSUs with Market Conditions Number of Units Weighted Average Grant Date Fair Value (per unit) Nonvested at January 1, 2024 — $ — Granted (a) 69,000 35.83 Vested — — Forfeited — — Nonvested at March 31, 2024 69,000 $ 35.83 (a) During the three months ended March 31, 2024, the Company granted RSUs with market conditions that will vest if the Company's 45 trading day average closing stock prices equals or exceeds certain price hurdles ($41.17, $52.94 and $64.70) during the performance period of March 1, 2024 to March 1, 2028. Upon achievement of each price hurdle, one-half of the awards will vest immediately, and the other half of the awards will vest on the first anniversary of the achievement date. For purposes of determining stock-based compensation expense, the weighted average grant date fair value per share of the RSUs with market conditions was estimated using the Monte Carlo simulation model, which requires the use of various key assumptions. Expected term (1) 5.00 years Expected volatility (2) 68.06 % Risk-free interest rate (3) 4.13 % Expected dividend (4) — (1) The expected term of RSUs with market conditions granted was calculated using a four-year performance period plus one year to account for the time-based vesting requirement. (2) The expected volatility rate is based on the historical volatility of the Company's common stock. (3) The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the awards, in effect at the grant date. (4) For all RSUs with market conditions granted, no dividends are expected to be paid over the contractual term of the stock options, resulting in a zero expected dividend rate. Employee Stock Purchase Plan In 2021, the Company implemented an employee stock purchase plan (“ESPP”), under which a total of 262,731 shares of the Company's common stock were reserved for issuance. As of March 31, 2024, 162,264 shares of common stock were available for issuance under the ESPP. The ESPP is a tax-qualified plan under Section 423 of the Internal Revenue Code. Under the terms of the ESPP, eligible employees are granted options to purchase shares of the Company's common stock at 85% of the lesser of (1) the fair market value at time of grant or (2) the fair market value at time of exercise. The offering periods and purchase periods are typically six-month periods ending on June 30 and December 31 of each year. No shares were issued under the ESPP during the three months ended March 31, 2024. During the three months ended March 31, 2024 and 2023, the Company granted employee stock purchase rights to certain employees with a grant date fair value per share of $11.27 and $8.19, respectively, calculated using the Black-Scholes option pricing model. For purposes of determining stock-based compensation expense, the grant date fair value per share estimated using the Black-Scholes option pricing model required the use of the following key assumptions: Three Months Ended 2024 2023 Expected term (1) 0.50 years 0.50 years Expected dividend (2) — — Expected volatility (3) 82 % 82% Risk-free interest rate (4) 5.28 % 4.76% (1) The expected term was calculated using the time period between the grant date and the purchase date. (2) No dividends are expected to be paid, resulting in a zero expected dividend rate. (3) The expected volatility rate is based on the historical volatility of the Company's common stock. (4) The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the employee stock purchase rights, in effect at the grant date.

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Three Months Ended 2024 2023 (in thousands, except percentages) Income tax expense $ (559) $ (395) Effective tax rate 35.5 % 2.9 %

DEBT

DEBT	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
DEBT	DEBT Convertible Senior Notes 2025 Notes On July 24, 2020, the Company issued $575.0 million aggregate principal amount of its 0.50% Convertible Senior Notes due July 15, 2025 (the “2025 Notes”) in a private placement. The 2025 Notes bear interest at a rate of 0.50% per year, payable semi-annually on January 15 and July 15 of each year, beginning on January 15, 2021. The 2025 Notes will mature on July 15, 2025, unless earlier repurchased, redeemed or converted. The initial conversion rate of the 2025 Notes is 2.1683 shares of the Company's common stock per $1,000 principal amount of 2025 Notes (which is equivalent to an initial conversion price of approximately $461.19 per share). On March 8, 2023, the Company repurchased approximately $190.6 million in principal amount of its 2025 Notes, through individual privately-negotiated transactions with certain holders of the 2025 Notes, for $156.3 million in cash plus accrued and unpaid interest of approximately $0.1 million. On December 7, 2023, the Company repurchased approximately $100.2 million in principal amount of its 2025 Notes, through individual privately-negotiated transactions with certain holders of the 2025 Notes, for $81.2 million in cash plus accrued and unpaid interest of approximately $0.2 million. During the year ended December 31, 2023, the Company recognized a gain on the extinguishment of debt of $53.3 million, a loss on the write-off of unamortized debt issuance costs of $3.2 million and incurred debt repayment costs of $1.6 million, all of which are included in interest (expense) income, net in the consolidated statements of operations and comprehensive income. Holders of the 2025 Notes were not entitled to convert the 2025 Notes during the calendar quarter ended March 31, 2024 as the last reported sale price of the Company's common stock, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on December 31, 2023, was not greater than or equal to 130% of the conversion price of the 2025 Notes on each applicable trading day. In the first three months of 2024, the Company recorded interest expense on the 2025 Notes of $0.8 million which consisted of $0.4 million associated with the 0.50% coupon rate and $0.4 million associated with the amortization of the debt issuance costs. In the first three months of 2023, the Company recorded interest expense on the 2025 Notes of $1.4 million which consisted of $0.7 million associated with the 0.50% coupon rate and $0.7 million associated with the amortization of the debt issuance costs. As of March 31, 2024, the fair value of the 2025 Notes is estimated to be approximately $265.0 million using the Level 1 observable input of the last quoted market price on March 31, 2024. A summary of the gross carrying amount, debt issuance costs, and net carrying value of the 2025 Notes, all of which is recorded as a non-current liability in the March 31, 2024 consolidated balance sheet, are as follows (in thousands) : March 31, December 31, Gross carrying amount $ 284,188 $ 284,188 Debt issuance costs 1,945 2,321 Net carrying amount $ 282,243 $ 281,867 Convertible Note Hedge and Warrant Transactions 2020 Hedge and Warrants On July 24, 2020, in connection with the issuance of the 2025 Notes, the Company entered into Convertible Note Hedge (the “2020 Hedge”) and warrant transactions with respect to the Company’s common stock. The 2020 Hedge transactions cover 1.2 million shares of the Company’s common stock, the same number of shares initially underlying the 2025 Notes, and are exercisable upon any conversion of the 2025 Notes. The 2020 Hedge transactions are expected generally to reduce the potential dilution to the Company’s common stock upon conversion of the 2025 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the converted 2025 Notes, as the case may be, in the event that the market price per share of common stock, as measured under the terms of the 2020 Hedge transactions, is greater than the strike price of the 2020 Hedge transactions, which initially corresponds to the initial conversion price of the 2025 Notes, or approximately $461.19 per share of common stock. The 2020 Hedge transactions will expire upon the maturity of the 2025 Notes. On July 24, 2020, the Company sold to the counterparties, warrants (the “2020 Warrants”) to acquire 1.2 million shares of the Company's common stock at an initial strike price of $709.52 per share, which represents a premium of 100% over the last reported sale price of the common stock of $354.76 on July 21, 2020. If the market price per share of the common stock, as measured under the terms of the 2020 Warrants, exceeds the strike price of the 2020 Warrants, the 2020 Warrants could have a dilutive effect, unless the Company elects, subject to certain conditions, to settle the 2020 Warrants in cash. In connection with the December 7, 2023 and the March 8, 2023 repurchases of the 2025 Notes noted above, the Company entered into agreements with the counterparties for the 2020 Hedge and 2020 Warrants transactions to terminate a portion of these call spread transactions effective December 7, 2023 and March 8, 2023, respectively, in notional amounts corresponding to the principal amount of the 2025 Notes repurchased. Subsequent to such terminations, the outstanding portion of the 2020 Hedge covers 0.6 million shares of the Company's common stock and the 2020 Warrants to acquire 0.6 million shares of the Company's common stock remain outstanding. 2021 Credit Facility On September 15, 2021, the Company entered into a credit agreement (the “Credit Agreement”), consisting of a $200.0 million revolving credit facility (the “Revolving Facility”), which matures on September 15, 2026, and a $250.0 million delayed draw term loan facility (the “2021 Term Loan” and together with the Revolving Facility, the “Credit Facility”), which matures on September 15, 2028. As of March 31, 2024, the Company had $246.3 million of borrowings outstanding under the 2021 Term Loan bearing interest at the SOFR option rate of 9.2% and had no borrowings under the Revolving Facility. As of December 31, 2023, the Company had $246.9 million of borrowings outstanding under the 2021 Term Loan and no borrowings under the Revolving Facility. As of March 31, 2024, borrowings of $3.1 million under the 2021 Term Loan are recorded as current portion of long-term debt on the consolidated balance sheet. At each of March 31, 2024 and December 31, 2023, the Company had outstanding one letter of credit issued in the amount of $0.2 million. The Company was in compliance with all covenants at March 31, 2024. In the first three months of 2024, the Company recorded interest expense related to its Revolving Facility of $0.4 million which consisted of $0.2 million in unused commitment fees and $0.2 million associated with the amortization of the debt issuance costs. In the first three months of 2024, the Company recorded interest expense related to the 2021 Term Loan of $5.7 million associated with borrowings bearing interest at the SOFR rate. In the first three months of 2023, the Company recorded interest expense related to its Revolving Facility of $0.4 million which consisted of $0.2 million in unused commitment fees and $0.2 million associated with the amortization of the debt issuance costs. In the first three months of 2023, the Company recorded interest expense related to the 2021 Term Loan of $5.2 million associated with borrowings bearing interest at the LIBO rate. 2024 Term Loan On March 27, 2024, the Company entered into a $175.0 million first lien term loan facility (the “2024 Term Loan”), which matures on March 27, 2031. The Company drew $125.0 million of the 2024 Term Loan upon closing while the remaining $50.0 million will be available as a delayed draw term loan until March 27, 2025. The proceeds of the 2024 Term Loan made on March 27, 2024 will be used to pay fees and expenses incurred in connection with the closing of the 2024 Term Loan and delayed draw term loan, and will be used for working capital and general corporate purposes, which may include repayment of the 2025 Notes. As of March 31, 2024, the Company had $125.0 million borrowings outstanding under the 2024 Term Loan bearing interest at the SOFR rate of 11.08%. As of March 31, 2024, borrowings of $12.5 million under the 2024 Term Loan are recorded as current portion of long-term debt on the consolidated balance sheet. The 2024 Term Loan is pre-payable at par, after 12 months of call protection (during which time prepayment would be at 101% of par), or with respect to prepayments made with respect to a change of control, at 101% of par, and carries a seven-year term. The Company's borrowings under the 2024 Term Loan bear interest at annual rates at (i) a SOFR rate on a daily basis applicable for an interest period of one month and (ii) 5.75%, with the opportunity for a one-time 25 basis point step-down at a gross first lien leverage ratio less than or equal to 3.75x after six fiscal quarters from the date of closing. The 2024 Term Loan has certain financial covenants which are tested on a quarterly basis. The covenants include a requirement for the Company to have a minimum cash balance of $40.0 million and a minimum Consolidated EBITDA (as such term is defined in the 2024 Term Loan agreement dated as of March 27, 2024) based on the applicable quarter. The Company was in compliance with all covenants at March 31, 2024. In addition, the 2024 Term Loan contains mandatory prepayment events, affirmative and negative covenants and events of default customary for a transaction of this type. The covenants, among other things, restrict additional indebtedness, liens, mergers or certain fundamental changes, asset dispositions, dividends and other restricted payments, transactions with affiliates, loans and investments and other matters customarily restricted in agreements of this type, all subject to certain exceptions. In addition, the Company is required to file an ATM Shelf Registration (as defined in the 2024 Term Loan agreement) with the SEC. In the event of a default in the minimum Consolidated EBITDA covenant, the Company is required to utilize the ATM Equity Program (as defined in the 2024 Term Loan agreement) to sell common stock and use the proceeds to cure the event of default in the minimum Consolidated EBITDA covenant. The Company is required to make mandatory prepayments of the outstanding principal amount of loans under the 2024 Term Loan with the net cash proceeds from certain disposition of assets and the receipt of insurance proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The 2024 Term Loan includes customary events of default, that include among other things, non-payment of principal, interest or fees, inaccuracy of representations and warranties, violation of certain covenants, cross default to certain other indebtedness, bankruptcy and insolvency events, material judgments, change of control, and certain material ERISA events. The occurrence of a default could result in the acceleration of the obligations under the facility. As security for its obligations under the facility, the Company granted a security interest to substantially all of the Company’s assets and the assets of its material subsidiaries, subject to certain exceptions. With respect to the 2024 Term Loan, the Company incurred financing costs of $7.3 million upon closing consisting of $4.2 million of debt issuance costs and $3.1 million of original issue discount which are being amortized to interest expense over the life of the 2024 Term Loan. Additionally, the Company is required to pay an unused commitment fee quarterly in arrears in an amount equal to 1.50% per annum on the amount of the undrawn portion of the delayed draw term loan commitments under the 2024 Term Loan. In the first three months of 2024, the Company recorded interest expense related to the 2024 Term Loan of $0.2 million which consisted of $0.2 million associated with borrowings bearing interest at the SOFR rate and immaterial amounts associated with unused commitment fees, the amortization of debt issuance costs, and accretion of the original issue discount. A summary of the gross carrying amount, debt issuance costs, original issue discount, and net carrying value of the 2024 Term Loan in the March 31, 2024 consolidated balance sheet, are as follows (in thousands) : March 31, Current Portion Gross carrying amount $ 12,500 Debt issuance costs 414 Unamortized original issue discount 312 Net carrying amount $ 11,774 Long-term Portion Gross carrying amount $ 112,500 Debt issuance costs 3,728 Unamortized original issue discount 2,807 Net carrying amount $ 105,965

CONTINGENCIES

CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Overview LendingTree is involved in legal proceedings on an ongoing basis. In assessing the materiality of a legal proceeding, the Company evaluates, among other factors, the amount of monetary damages claimed, as well as the potential impact of non-monetary remedies sought by plaintiffs (e.g., injunctive relief) that may require it to change its business practices in a manner that could have a material and adverse impact on the Company's business. With respect to the matters disclosed in this Note 13, unless otherwise indicated, the Company is unable to estimate the possible loss or range of losses that could potentially result from the application of such non-monetary remedies. As of March 31, 2024 and December 31, 2023, the Company had litigation settlement accruals of $0.7 million and $0.6 million, respectively. The litigation settlement accruals relate to litigation matters that were either settled or a firm offer for settlement was extended, thereby establishing an accrual amount that is both probable and reasonably estimable.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Other than the convertible notes and warrants, as well as the equity interests, the carrying amounts of the Company's financial instruments are equal to fair value at March 31, 2024. See Note 12—Debt for additional information on the convertible notes and warrants.

SEGMENT INFORMATION

SEGMENT INFORMATION	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company manages its business and reports its financial results through the following three operating and reportable segments: Home, Consumer, and Insurance. Characteristics which were relied upon in making the determination of the reportable segments include the nature of the products, the organization's internal structure, and the information that is regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources. The Home segment includes the following products: purchase mortgage, refinance mortgage, and home equity loans and lines of credit. The Consumer segment includes the following products: credit cards, personal loans, small business loans, student loans, auto loans, deposit accounts, and other credit products such as credit repair and debt settlement. The credit repair business was closed at the end of the second quarter of 2023. The Insurance segment consists of insurance quote products and sales of insurance policies in the agency businesses. The following tables are a reconciliation of segment profit, which is the Company's primary segment profitability measure, to income before income taxes. Segment marketing expense represents the portion of selling and marketing expense attributable to variable costs paid for advertising, direct marketing and related expenses, that are directly attributable to the segments' products. This measure excludes overhead, fixed costs and personnel-related expenses. Three Months Ended March 31, 2024 Home Consumer Insurance Other Total (in thousands) Revenue $ 30,443 $ 51,451 $ 85,872 $ 2 $ 167,768 Segment marketing expense 20,833 24,011 52,423 (21) 97,246 Segment profit 9,610 27,440 33,449 23 70,522 Cost of revenue 8,545 Brand and other marketing expense 10,930 General and administrative expense 25,796 Product development 11,857 Depreciation 4,667 Amortization of intangibles 1,489 Restructuring and severance 23 Litigation settlements and contingencies 36 Operating income 7,179 Interest expense, net (6,638) Other income 1,034 Income before income taxes $ 1,575 Three Months Ended March 31, 2023 Home Consumer Insurance Other Total (in thousands) Revenue $ 43,675 $ 79,709 $ 77,082 $ 42 $ 200,508 Segment marketing expense 28,567 44,833 46,930 221 120,551 Segment profit (loss) 15,108 34,876 30,152 (179) 79,957 Cost of revenue 13,760 Brand and other marketing expense 16,560 General and administrative expense 36,683 Product development 14,655 Depreciation 4,795 Amortization of intangibles 2,049 Restructuring and severance 4,454 Litigation settlements and contingencies 12 Operating loss (13,011) Interest income, net 25,029 Other income 1,834 Income before income taxes $ 13,852

RESTRUCTURING ACTIVITIES

RESTRUCTURING ACTIVITIES	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING ACTIVITIES	RESTRUCTURING ACTIVITIES During September 2023, the Company initiated workforce reductions of 14 employees. The Company incurred approximately $0.9 million in severance charges in connection with the workforce reductions, consisting of cash expenditures for employee separation costs of approximately $0.7 million and non-cash charges for the accelerated vesting of certain equity awards of approximately $0.2 million. The cash payments are expected to be substantially completed by the third quarter of 2024. On April 6, 2023, the Company made the decision to close the Ovation credit services business ( the "Ovation Closure".) The Ovation Closure included the elimination of approximately 197 employees, or 18%, of the Company's workforce. As a result of the Ovation Closure, the Company incurred $2.1 million in restructuring expense in connection with cash expenditures for employee separation costs. The Ovation Closure, including cash payments, was completed in the first quarter of 2024. In connection with the Ovation Closure, in the first quarter of 2023, the Company recorded asset impairment charges of $4.2 million, of which $2.1 million related to intangible assets, $1.7 million related to property and equipment, and $0.4 million related to an operating lease right-of-use asset. On March 24, 2023, the Company committed to a workforce reduction plan (the “Reduction Plan”), to reduce operating costs. The Reduction Plan included the elimination of approximately 162 employees, or 13%, of the Company’s workforce. As a result of the Reduction Plan, the Company incurred approximately $5.3 million in severance charges in connection with the workforce reduction, consisting of cash expenditures for employee separation costs of approximately $4.3 million and non-cash charges for the accelerated vesting of certain equity awards of approximately $1.0 million. The Company incurred restructuring expense of $4.3 million in the first quarter of 2023 related to the Reduction Plan. The Reduction Plan, including cash payments, is expected to be substantially completed by the end of the third quarter of 2024. Accrued Balance at December 31, 2023 Income Statement Impact Payments Accrued Balance at March 31, 2024 Q3 2023 action Employee separation payments $ 254 $ (7) $ (82) $ 165 Q2 2023 action Employee separation payments 34 4 (38) — Q1 2023 action Employee separation payments 421 15 (181) 255 $ 709 $ 12 $ (301) $ 420

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS In April 2024, the Company repurchased approximately $37.7 million in principal amount of its 2025 Notes, through individual privately-negotiated transactions with certain holders of the 2025 Notes, for $35.3 million in cash plus accrued and unpaid interest.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 1,016	$ 13,457

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Accounting Estimates	Accounting Estimates Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. The Company considered the impact of the current economic conditions, including interest rates and inflation on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional information is obtained. If economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.
Certain Risks and Concentrations	Certain Risks and Concentrations LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and fraud. Financial instruments, which potentially subject the Company to concentration of credit risk at March 31, 2024, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which in the event of non-payment, would be applied against any accounts receivable outstanding. Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace. Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service. Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.
Litigation Settlements and Contingencies	Litigation Settlements and Contingencies Litigation settlements and contingencies consists of expenses related to actual or anticipated litigation settlements.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2023-07 which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. This ASU is effective for annual periods beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, including adoption in interim periods. An entity should adopt the guidance as of the beginning of the earliest period presented. The Company is evaluating the impact this ASU will have on its consolidated financial statements and whether to early adopt. In December 2023, the FASB issued ASU 2023-09 which expands annual disclosure requirements for income taxes, primarily through disclosure about disaggregated information about an entity's effective tax rate reconciliation and information on income taxes paid. This ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The guidance will be applied on a prospective basis with the option to adopt the guidance retrospectively. The Company is evaluating the impact this ASU will have on its consolidated financial statements and whether to early adopt.
Equity Investments	The equity investments do not have a readily determinable fair value and, upon acquisition, the Company elected the measurement alternative to value its investments. Accordingly, the equity investments will be carried at cost less impairment, if any, and subsequently measured to fair value upon observable price changes in an orderly transaction for the identical or similar investments. Additionally, if a qualitative assessment identifies impairment indicators, then the equity investments must be evaluated for impairment and written down to its fair value, if it is determined that the fair value is less than the carrying value. Any gains or losses are included within other income (expense) in the consolidated statement of operations and comprehensive income.

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Revenue is as follows (in thousands) : Three Months Ended 2024 2023 Home $ 30,443 $ 43,675 Personal loans 20,127 23,599 Other Consumer 31,324 56,110 Total Consumer 51,451 79,709 Insurance 85,872 77,082 Other 2 42 Total revenue $ 167,768 $ 200,508

CASH AND RESTRICTED CASH (Table

CASH AND RESTRICTED CASH (Tables)	3 Months Ended
	Mar. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	Total cash, cash equivalents, restricted cash and restricted cash equivalents consist of the following (in thousands) : March 31, December 31, Cash and cash equivalents $ 230,745 $ 112,051 Restricted cash and cash equivalents 16 5 Total cash, cash equivalents, restricted cash and restricted cash equivalents $ 230,761 $ 112,056
Schedule of Cash and Cash Equivalents	Total cash, cash equivalents, restricted cash and restricted cash equivalents consist of the following (in thousands) : March 31, December 31, Cash and cash equivalents $ 230,745 $ 112,051 Restricted cash and cash equivalents 16 5 Total cash, cash equivalents, restricted cash and restricted cash equivalents $ 230,761 $ 112,056

ALLOWANCE FOR DOUBTFUL ACCOUN_2

ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)	3 Months Ended
	Mar. 31, 2024
Credit Loss [Abstract]
Reconciliation of Allowance For Doubtful Accounts	A reconciliation of the beginning and ending balances of the allowance for doubtful accounts is as follows (in thousands) : Three Months Ended 2024 2023 Balance, beginning of the period $ 2,222 $ 2,317 Charges to earnings (129) 963 Write-off of uncollectible accounts receivable (67) (963) Assets held for sale — 371 Balance, end of the period $ 2,026 $ 2,688

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Balance of Goodwill, Net and Intangible Assets, Net	The balance of goodwill, net and intangible assets, net is as follows (in thousands) : March 31, December 31, Goodwill $ 903,227 $ 903,227 Accumulated impairment losses (521,688) (521,688) Net goodwill $ 381,539 $ 381,539 Intangible assets with indefinite lives $ 10,142 $ 10,142 Intangible assets with definite lives, net 38,990 40,478 Total intangible assets, net $ 49,132 $ 50,620
Schedule of Intangible Assets with Definite Lives	Intangible assets with definite lives relate to the following (in thousands) : Cost Accumulated Net Customer lists 76,100 (37,110) 38,990 Balance at March 31, 2024 $ 76,100 $ (37,110) $ 38,990 Cost Accumulated Net Customer lists $ 76,100 $ (35,644) $ 40,456 Trademarks and tradenames 1,300 (1,278) 22 Balance at December 31, 2023 $ 77,400 $ (36,922) $ 40,478
Schedule of Amortization of Intangible Assets with Definite Lives	Amortization of intangible assets with definite lives is computed on a straight-line basis and, based on balances as of March 31, 2024, future amortization is estimated to be as follows (in thousands) : Amortization Expense Remainder of current year $ 4,401 Year ending December 31, 2025 5,830 Year ending December 31, 2026 5,504 Year ending December 31, 2027 5,198 Year ending December 31, 2028 4,685 Thereafter 13,372 Total intangible assets with definite lives, net $ 38,990

ACCRUED EXPENSES AND OTHER CU_2

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following (in thousands) : March 31, December 31, Accrued advertising expense $ 37,334 $ 27,859 Accrued compensation and benefits 8,072 15,091 Accrued professional fees 816 1,101 Customer deposits and escrows 7,113 7,732 Current lease liabilities 6,637 7,387 Other 9,745 11,374 Total accrued expenses and other current liabilities $ 69,717 $ 70,544

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Income per Share	Basic and diluted income per share was determined based on the following share data (in thousands) : Three Months Ended 2024 2023 Weighted average basic common shares 13,100 12,846 Effect of stock options 61 54 Effect of dilutive share awards 115 35 Weighted average diluted common shares 13,276 12,935

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Non-cash Compensation Related to Equity Awards	Non-cash compensation related to equity awards is included in the following line items in the accompanying consolidated statements of operations and comprehensive income (in thousands) : Three Months Ended 2024 2023 Cost of revenue $ 95 $ 214 Selling and marketing expense 1,024 1,744 General and administrative expense 5,333 7,343 Product development 1,337 1,902 Restructuring and severance — 71 Total non-cash compensation $ 7,789 $ 11,274
Summary of Changes in Outstanding Stock Options	A summary of changes in outstanding stock options is as follows: Number of Options Weighted Weighted Aggregate Intrinsic Value (a) (per option) (in years) (in thousands) Options outstanding at January 1, 2024 734,775 $ 150.74 Granted — — Exercised (54,103) 23.80 Forfeited — — Expired — — Options outstanding at March 31, 2024 680,672 160.83 3.74 $ 3,199 Options exercisable at March 31, 2024 590,523 $ 148.04 3.23 $ 3,199 (a)
Summary of Changes in Outstanding Stock Options with Market Conditions	A summary of changes in outstanding stock options with market conditions at target is as follows: Number of Options with Market Conditions Weighted Weighted Aggregate Intrinsic Value (a) (per option) (in years) (in thousands) Options outstanding at January 1, 2024 718,438 $ 229.02 Granted — — Exercised — — Forfeited — — Expired (19,126) 275.82 Options outstanding at March 31, 2024 699,312 227.74 4.39 $ — Options exercisable at March 31, 2024 481,669 $ 195.10 3.35 $ — (a) The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company's closing stock price of $42.34 on the last trading day of the quarter ended March 31, 2024 and the exercise price, multiplied by the number of shares covered by in-the-money options) that would have been received by the option holder had the option holder exercised these options on March 31, 2024. The intrinsic value changes based on the market value of the Company's common stock.
Summary of Changes in Outstanding Nonvested RSUs with Performance Conditions and Nonvested RSAs with Market Conditions	A summary of changes in outstanding nonvested restricted stock units (“RSUs”) is as follows: RSUs Number of Units Weighted Average Grant Date Fair Value (per unit) Nonvested at January 1, 2024 471,593 $ 66.42 Granted 363,765 39.93 Vested (194,992) 76.76 Forfeited (17,931) 55.31 Nonvested at March 31, 2024 622,435 $ 48.02 A summary of changes in outstanding nonvested RSUs with performance conditions is as follows: RSUs with Market Conditions Number of Units Weighted Average Grant Date Fair Value (per unit) Nonvested at January 1, 2024 — $ — Granted (a) 69,000 35.83 Vested — — Forfeited — — Nonvested at March 31, 2024 69,000 $ 35.83 (a)
Summary of RSUs with Market Conditions Valuation Assumptions	For purposes of determining stock-based compensation expense, the weighted average grant date fair value per share of the RSUs with market conditions was estimated using the Monte Carlo simulation model, which requires the use of various key assumptions. Expected term (1) 5.00 years Expected volatility (2) 68.06 % Risk-free interest rate (3) 4.13 % Expected dividend (4) — (1) The expected term of RSUs with market conditions granted was calculated using a four-year performance period plus one year to account for the time-based vesting requirement. (2) The expected volatility rate is based on the historical volatility of the Company's common stock. (3) The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the awards, in effect at the grant date. (4) For all RSUs with market conditions granted, no dividends are expected to be paid over the contractual term of the stock options, resulting in a zero expected dividend rate.
Summary of Employee Stock Purchase Plan Valuation Assumptions	For purposes of determining stock-based compensation expense, the grant date fair value per share estimated using the Black-Scholes option pricing model required the use of the following key assumptions: Three Months Ended 2024 2023 Expected term (1) 0.50 years 0.50 years Expected dividend (2) — — Expected volatility (3) 82 % 82% Risk-free interest rate (4) 5.28 % 4.76% (1) The expected term was calculated using the time period between the grant date and the purchase date. (2) No dividends are expected to be paid, resulting in a zero expected dividend rate. (3) The expected volatility rate is based on the historical volatility of the Company's common stock. (4) The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the employee stock purchase rights, in effect at the grant date.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income Tax (Expense) Benefit and Effective Tax Rate	Three Months Ended 2024 2023 (in thousands, except percentages) Income tax expense $ (559) $ (395) Effective tax rate 35.5 % 2.9 %

DEBT (Table)

DEBT (Table)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Component of the Notes	A summary of the gross carrying amount, debt issuance costs, and net carrying value of the 2025 Notes, all of which is recorded as a non-current liability in the March 31, 2024 consolidated balance sheet, are as follows (in thousands) : March 31, December 31, Gross carrying amount $ 284,188 $ 284,188 Debt issuance costs 1,945 2,321 Net carrying amount $ 282,243 $ 281,867
Summary of Current and Long-Term Portion of Debt	A summary of the gross carrying amount, debt issuance costs, original issue discount, and net carrying value of the 2024 Term Loan in the March 31, 2024 consolidated balance sheet, are as follows (in thousands) : March 31, Current Portion Gross carrying amount $ 12,500 Debt issuance costs 414 Unamortized original issue discount 312 Net carrying amount $ 11,774 Long-term Portion Gross carrying amount $ 112,500 Debt issuance costs 3,728 Unamortized original issue discount 2,807 Net carrying amount $ 105,965

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	The following tables are a reconciliation of segment profit, which is the Company's primary segment profitability measure, to income before income taxes. Segment marketing expense represents the portion of selling and marketing expense attributable to variable costs paid for advertising, direct marketing and related expenses, that are directly attributable to the segments' products. This measure excludes overhead, fixed costs and personnel-related expenses. Three Months Ended March 31, 2024 Home Consumer Insurance Other Total (in thousands) Revenue $ 30,443 $ 51,451 $ 85,872 $ 2 $ 167,768 Segment marketing expense 20,833 24,011 52,423 (21) 97,246 Segment profit 9,610 27,440 33,449 23 70,522 Cost of revenue 8,545 Brand and other marketing expense 10,930 General and administrative expense 25,796 Product development 11,857 Depreciation 4,667 Amortization of intangibles 1,489 Restructuring and severance 23 Litigation settlements and contingencies 36 Operating income 7,179 Interest expense, net (6,638) Other income 1,034 Income before income taxes $ 1,575 Three Months Ended March 31, 2023 Home Consumer Insurance Other Total (in thousands) Revenue $ 43,675 $ 79,709 $ 77,082 $ 42 $ 200,508 Segment marketing expense 28,567 44,833 46,930 221 120,551 Segment profit (loss) 15,108 34,876 30,152 (179) 79,957 Cost of revenue 13,760 Brand and other marketing expense 16,560 General and administrative expense 36,683 Product development 14,655 Depreciation 4,795 Amortization of intangibles 2,049 Restructuring and severance 4,454 Litigation settlements and contingencies 12 Operating loss (13,011) Interest income, net 25,029 Other income 1,834 Income before income taxes $ 13,852

RESTRUCTURING ACTIVITIES (Table

RESTRUCTURING ACTIVITIES (Tables)	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Rollforward of Accrued Balance for Restructuring Activities	Accrued Balance at December 31, 2023 Income Statement Impact Payments Accrued Balance at March 31, 2024 Q3 2023 action Employee separation payments $ 254 $ (7) $ (82) $ 165 Q2 2023 action Employee separation payments 34 4 (38) — Q1 2023 action Employee separation payments 421 15 (181) 255 $ 709 $ 12 $ (301) $ 420

REVENUE - Disaggregation of Rev

REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 167,768	$ 200,508
Other
Disaggregation of Revenue [Line Items]
Revenue	2	42
Home
Disaggregation of Revenue [Line Items]
Revenue	30,443	43,675
Personal loans
Disaggregation of Revenue [Line Items]
Revenue	20,127	23,599
Other Consumer
Disaggregation of Revenue [Line Items]
Revenue	31,324	56,110
Total Consumer
Disaggregation of Revenue [Line Items]
Revenue	51,451	79,709
Insurance
Disaggregation of Revenue [Line Items]
Revenue	$ 85,872	$ 77,082

REVENUE - Narrative (Details)

REVENUE - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Contract asset	$ 15.1		$ 13.7
Contract liability			$ 0
Revenue recognized from prior period		$ 0.8
Estimated variable consideration, increase in revenue	$ 0.3	$ 0.2

CASH AND RESTRICTED CASH (Detai

CASH AND RESTRICTED CASH (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 230,745	$ 112,051
Restricted cash and cash equivalents	16	5
Total cash, cash equivalents, restricted cash and restricted cash equivalents	$ 230,761	$ 112,056	$ 150,108	$ 298,969

ALLOWANCE FOR DOUBTFUL ACCOUN_3

ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance, beginning of the period	$ 2,222	$ 2,317
Charges to earnings	(129)	963
Write-off of uncollectible accounts receivable	(67)	(963)
Assets held for sale	0	371
Balance, end of the period	$ 2,026	$ 2,688

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Schedule of Balance of Goodwill, Net and Intangible Assets, Net (Details ) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 903,227	$ 903,227
Accumulated impairment losses	(521,688)	(521,688)
Net goodwill	381,539	381,539
Intangible assets with indefinite lives	10,142	10,142
Intangible assets with definite lives, net	38,990	40,478
Total intangible assets, net	$ 49,132	$ 50,620

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Mar. 31, 2024	Dec. 31, 2023
Intangible assets with definite lives
Goodwill		$ 903,227	$ 903,227
Home
Intangible assets with definite lives
Goodwill		59,300	59,300
Goodwill impairment	$ 0
Total Consumer
Intangible assets with definite lives
Goodwill		166,100	166,100
Goodwill impairment	0
Insurance
Intangible assets with definite lives
Goodwill		$ 156,100	$ 156,100
Goodwill impairment	$ 38,600

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets with Definite Lives (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Intangible assets with definite lives
Cost	$ 76,100	$ 77,400
Accumulated Amortization	(37,110)	(36,922)
Total intangible assets with definite lives, net	38,990	40,478
Customer lists
Intangible assets with definite lives
Cost	76,100	76,100
Accumulated Amortization	(37,110)	(35,644)
Total intangible assets with definite lives, net	$ 38,990	40,456
Trademarks and tradenames
Intangible assets with definite lives
Cost		1,300
Accumulated Amortization		(1,278)
Total intangible assets with definite lives, net		$ 22

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS - Schedule of Amortization of Intangible Assets with Definite Lives (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Amortization of intangible assets with definite lives computed on a straight-line basis
Remainder of current year	$ 4,401
2025	5,830
2026	5,504
2027	5,198
2028	4,685
Thereafter	13,372
Total intangible assets with definite lives, net	$ 38,990	$ 40,478

EQUITY INVESTMENTS (Details)

EQUITY INVESTMENTS (Details) $ in Millions	3 Months Ended
	Sep. 30, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Loss on impairment of investments	$ 113.1

ACCRUED EXPENSES AND OTHER CU_3

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accrued expenses and other current liabilities
Accrued advertising expense	$ 37,334	$ 27,859
Accrued compensation and benefits	8,072	15,091
Accrued professional fees	816	1,101
Customer deposits and escrows	7,113	7,732
Current lease liabilities	6,637	7,387
Other	9,745	11,374
Total accrued expenses and other current liabilities	$ 69,717	$ 70,544

SHAREHOLDERS' EQUITY (Details)

SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Jul. 24, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average basic common shares (in shares)	13,100,000	12,846,000
Effect of stock options (in shares)	61,000	54,000
Effect of dilutive share awards (in shares)	115,000	35,000
Weighted average diluted common shares (in shares)	13,276,000	12,935,000
Common stock repurchases
Purchased shares of common stock under stock repurchase program (in shares)	0	0
Remaining authorized repurchase amount	$ 96.7
2025 Convertible Notes
Additional disclosure
Stated interest rate	0.50%
2025 Convertible Notes | Convertible Debt
Additional disclosure
Stated interest rate	0.50%		0.50%
Option
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	1,000,000	1,000,000
Restricted Stock Units (RSUs)
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	300,000	400,000
Convertible Debt
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	600,000	1,200,000

STOCK-BASED COMPENSATION - Sche

STOCK-BASED COMPENSATION - Schedule of Non-cash Compensation Related to Equity Awards (Details ) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total non-cash compensation	$ 7,789	$ 11,274
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total non-cash compensation	95	214
Selling and marketing expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total non-cash compensation	1,024	1,744
General and administrative expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total non-cash compensation	5,333	7,343
Product development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total non-cash compensation	1,337	1,902
Restructuring and severance
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total non-cash compensation	$ 0	$ 71

STOCK-BASED COMPENSATION - Summ

STOCK-BASED COMPENSATION - Summary of Stock Options and Stock Options with Market Conditions (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Stock options, Grant Date Fair Value Valuation
Share price (in dollars per share) | $ / shares	$ 42.34
Option
Stock options, Shares
Outstanding at the beginning of the period (in shares)	734,775
Granted (in shares)	0
Exercised (in shares)	(54,103)
Forfeited (in shares)	0
Expired (in shares)	0
Outstanding at the end of the period (in shares)	680,672
Options exercisable at the end of the period (in shares)	590,523
Stock options, Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 150.74
Granted (in dollars per share) | $ / shares	0
Exercised (in dollars per share) | $ / shares	23.80
Forfeited (in dollars per share) | $ / shares	0
Expired (in dollars per share) | $ / shares	0
Outstanding at the end of the period (in dollars per share) | $ / shares	160.83
Options exercisable at the end of the period (in dollars per share) | $ / shares	$ 148.04
Stock options, Weighted Average Remaining Contractual Term
Options outstanding at the end of the period (in years)	3 years 8 months 26 days
Options exercisable at the end of the period (in years)	3 years 2 months 23 days
Stock options, Aggregate Intrinsic Value
Outstanding at the end of the period | $	$ 3,199
Options exercisable at the end of the period | $	$ 3,199
Market options
Stock options, Shares
Outstanding at the beginning of the period (in shares)	718,438
Granted (in shares)	0
Exercised (in shares)	0
Forfeited (in shares)	0
Expired (in shares)	(19,126)
Outstanding at the end of the period (in shares)	699,312
Options exercisable at the end of the period (in shares)	481,669
Stock options, Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 229.02
Granted (in dollars per share) | $ / shares	0
Exercised (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	0
Expired (in dollars per share) | $ / shares	275.82
Outstanding at the end of the period (in dollars per share) | $ / shares	227.74
Options exercisable at the end of the period (in dollars per share) | $ / shares	$ 195.10
Stock options, Weighted Average Remaining Contractual Term
Options outstanding at the end of the period (in years)	4 years 4 months 20 days
Options exercisable at the end of the period (in years)	3 years 4 months 6 days
Stock options, Aggregate Intrinsic Value
Outstanding at the end of the period | $	$ 0
Options exercisable at the end of the period | $	$ 0
Stock options, Grant Date Fair Value Valuation
Maximum number of shared to be earned	363,464
Percentage of target number of shares	167%
Performance awards earned (in shares)	0

STOCK-BASED COMPENSATION - Su_2

STOCK-BASED COMPENSATION - Summary of RSA & RSU (Details)	3 Months Ended
	Mar. 31, 2024 day $ / shares shares
Nonvested RSUs and Restricted Stock Units,, Weighted Average Grant Date Fair Value
Share price (in dollars per share)	$ 42.34
Restricted Stock Units (RSUs)
Nonvested RSUs and Restricted Stock Units, Number of Shares
Nonvested at the beginning of the period (in shares) | shares	471,593
Granted (in shares) | shares	363,765
Vested (in shares) | shares	(194,992)
Forfeited (in shares) | shares	(17,931)
Nonvested at the end of the period (in shares) | shares	622,435
Nonvested RSUs and Restricted Stock Units,, Weighted Average Grant Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$ 66.42
Granted (in dollars per share)	39.93
Vested (in dollars per share)	76.76
Forfeited (in dollars per share)	55.31
Nonvested at the end of the period (in dollars per share)	$ 48.02
Market-Based Restricted Stock Units
Nonvested RSUs and Restricted Stock Units, Number of Shares
Nonvested at the beginning of the period (in shares) | shares	0
Granted (in shares) | shares	69,000
Vested (in shares) | shares	0
Forfeited (in shares) | shares	0
Nonvested at the end of the period (in shares) | shares	69,000
Nonvested RSUs and Restricted Stock Units,, Weighted Average Grant Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$ 0
Granted (in dollars per share)	35.83
Vested (in dollars per share)	0
Forfeited (in dollars per share)	0
Nonvested at the end of the period (in dollars per share)	$ 35.83
Vesting period if trading day average closing stock prices (in days) | day	45
Market-Based Restricted Stock Units | Vest Immediately
Nonvested RSUs and Restricted Stock Units,, Weighted Average Grant Date Fair Value
Share price (in dollars per share)	$ 41.17
Vesting percentage	50%
Market-Based Restricted Stock Units | Vest On First Anniversary of Achievement Date
Nonvested RSUs and Restricted Stock Units,, Weighted Average Grant Date Fair Value
Share price (in dollars per share)	$ 52.94
Vesting percentage	50%
Market-Based Restricted Stock Units | Share-Based Payment Arrangement, Tranche Three
Nonvested RSUs and Restricted Stock Units,, Weighted Average Grant Date Fair Value
Share price (in dollars per share)	$ 64.70

STOCK-BASED COMPENSATION - Su_3

STOCK-BASED COMPENSATION - Summary of RSUs with Market Conditions Valuation Assumptions (Details) - Market-Based Restricted Stock Units	3 Months Ended
	Mar. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years
Expected volatility	68.06%
Risk-free interest rate	4.13%
Expected dividend	0%
Performance period (in years)	4 years
Time-based vesting requirement (in years)	1 year

STOCK-BASED COMPENSATION - Empl

STOCK-BASED COMPENSATION - Employee Stock Purchase Plan (Details) - Employee Stock - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)	162,264		262,731
Purchase price of common stock, percent	85%
Offering period (in months)	6 months
Purchase period (in months)	6 months
Shares issued under ESPP (in shares)	0
Grant date fair value (in dollars per share)	$ 11.27	$ 8.19
Expected term (in years)	6 months	6 months
Expected dividend	0%	0%
Expected volatility	82%	82%
Risk-free interest rate	5.28%	4.76%
Expected dividends	$ 0

INCOME TAXES - Summary of Incom

INCOME TAXES - Summary of Income Tax Expense and Effective Tax Rate (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ (559)	$ (395)
Effective tax rate	35.50%	2.90%

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	21%	21%

DEBT - Convertible Senior Notes

DEBT - Convertible Senior Notes Narrative (Details)		3 Months Ended		12 Months Ended
	Jul. 24, 2020 USD ($) day $ / shares Rate shares	Mar. 31, 2024 USD ($) Rate	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 07, 2023 USD ($)	Mar. 08, 2023 USD ($)
Debt Instrument [Line Items]
Gain on extinguishment of debt		$ 0	$ 34,308,000
Write-off of previously-capitalized debt issuance costs		0	2,373,000
Amortization of debt issuance costs		$ 612,000	1,959,000
2025 Convertible Notes
Debt Instrument [Line Items]
Stated interest rate | Rate		0.50%
Initial conversion rate, shares per $1,000 principal amount of notes | shares	2.1683
Initial conversion price per share (in dollars per share) | $ / shares	$ 461.19
Debt repurchase amount					$ 100,200,000	$ 190,600,000
Fair value of debt repurchased					81,200,000	156,300,000
Debt repurchased amount, accrued interest					$ 200,000	$ 100,000
Gain on extinguishment of debt				$ 53,300,000
Write-off of previously-capitalized debt issuance costs				3,200,000
Debt prepayment costs				$ 1,600,000
Threshold trading days | day	20
Threshold consecutive trading days | day	30
Conversion rate, sales price of common stock as a percentage of the conversion price | Rate	130%
Interest expense		$ 800,000	1,400,000
Interest expense recognized associated with the coupon rate		400,000	700,000
Annual interest rate on convertible senior notes	0.50%
Amortization of debt issuance costs		$ 400,000	$ 700,000
2025 Convertible Notes | Convertible Debt
Debt Instrument [Line Items]
Aggregate principal amount	$ 575,000,000
Stated interest rate	0.50%	0.50%
Fair value		$ 265,000,000

DEBT - Components of Notes (Det

DEBT - Components of Notes (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Net carrying amount	$ 631,333	$ 525,617
2025 Convertible Notes
Debt Instrument [Line Items]
Gross carrying amount	284,188	284,188
Debt issuance costs	1,945	2,321
Net carrying amount	$ 282,243	$ 281,867

DEBT - Convertible Note Hedge a

DEBT - Convertible Note Hedge and Warrant Transactions (Details) - $ / shares shares in Millions	Mar. 31, 2024	Jul. 24, 2020	Jul. 21, 2020
Debt Instrument [Line Items]
Share price (in dollars per share)	$ 42.34
2020 Hedge and Warrants
Debt Instrument [Line Items]
Number of shares covered by the hedge transactions	0.6	1.2
Initial conversion price per share (in dollars per share)		$ 461.19
Strike price of warrants sold (in dollars per share)		$ 709.52
Premium of warrant strike price over sales price of common stock		100%
Share price (in dollars per share)			$ 354.76
Warrants outstanding (in shares)	0.6

DEBT - 2021 Credit Facility (De

DEBT - 2021 Credit Facility (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Sep. 15, 2021
Line of Credit Facility [Line Items]
Letters of credit outstanding	$ 200,000		$ 200,000
Amortization of debt issuance costs	612,000	$ 1,959,000
Credit Agreement | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 200,000,000
Interest expense	400,000	400,000
Unused commitment fees	200,000	200,000
Amortization of debt issuance costs	200,000	200,000
Credit Agreement | Delayed Draw Term Loan | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 250,000,000
Line of credit outstanding	246,300,000		246,900,000
Gross carrying amount	3,100,000
Interest expense	$ 5,700,000	$ 5,200,000
Credit Agreement | SOFR | Delayed Draw Term Loan | Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate	9.20%
Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Line of credit outstanding	$ 0		$ 0

DEBT - 2024 Term Loan (Details)

DEBT - 2024 Term Loan (Details) $ in Thousands		3 Months Ended
	Mar. 27, 2024 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Debt Instrument [Line Items]
Amortization of debt issuance costs		$ 612	$ 1,959
Amortization of debt discount		6	$ 0
Secured Debt | 2024 Term Loan | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 175,000
Amount drew down	125,000
Amount available as a delayed draw	$ 50,000
Line of credit outstanding		125,000
Gross carrying amount		12,500
Term after call protection that loan is pre-payable at par (in months)	12 months
Prepayment percentage	101%
Prepayment term (in years)	7 years
One-time step-down	0.25%
Gross first lien leverage ratio, maximum	3.75
Minimum cash balance	$ 40,000
Financing costs	7,300
Debt issuance cost	4,200
Original issue discount	$ 3,100
Unused capacity, commitment fee percentage	1.50%
Interest expense		200
Unused commitment fees		0
Amortization of debt issuance costs		0
Amortization of debt discount		$ 0
Secured Debt | 2024 Term Loan | Line of Credit | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate		11.08%
Prepayment basis spread	5.75%

DEBT - Summary of Current and L

DEBT - Summary of Current and Long-Term Portion of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Portion
Net carrying amount	$ 14,899	$ 3,125
Long-term Portion
Net carrying amount	631,333	$ 525,617
Secured Debt | 2024 Term Loan | Line of Credit
Current Portion
Gross carrying amount	12,500
Debt issuance costs	414
Unamortized original issue discount	312
Net carrying amount	11,774
Long-term Portion
Gross carrying amount	112,500
Debt issuance costs	3,728
Unamortized original issue discount	2,807
Net carrying amount	$ 105,965

CONTINGENCIES (Details)

CONTINGENCIES (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Accrued litigation liability	$ 0.7	$ 0.6

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) segment	Mar. 31, 2023 USD ($)
Segment Information
Number of operating segments | segment	3
Number of reportable segments | segment	3
Revenue	$ 167,768	$ 200,508
Segment marketing expense	97,246	120,551
Segment profit (loss)	70,522	79,957
Cost of revenue	8,545	13,760
Brand and other marketing expense	10,930	16,560
General and administrative expense	25,796	36,683
Product development	11,857	14,655
Depreciation	4,667	4,795
Amortization of intangibles	1,489	2,049
Restructuring and severance	23	4,454
Litigation settlements and contingencies	36	12
Operating income (loss)	7,179	(13,011)
Interest (expense) income, net	(6,638)	25,029
Other income	1,034	1,834
Income before income taxes	1,575	13,852
Home
Segment Information
Revenue	30,443	43,675
Segment marketing expense	20,833	28,567
Segment profit (loss)	9,610	15,108
Consumer
Segment Information
Revenue	51,451	79,709
Segment marketing expense	24,011	44,833
Segment profit (loss)	27,440	34,876
Insurance
Segment Information
Revenue	85,872	77,082
Segment marketing expense	52,423	46,930
Segment profit (loss)	33,449	30,152
Other
Segment Information
Revenue	2	42
Segment marketing expense	(21)	221
Segment profit (loss)	$ 23	$ (179)

RESTRUCTURING ACTIVITIES (Detai

RESTRUCTURING ACTIVITIES (Details) $ in Thousands			1 Months Ended	3 Months Ended		12 Months Ended	18 Months Ended
	Apr. 06, 2023 USD ($) employee	Mar. 24, 2023 USD ($) employee	Sep. 30, 2023 USD ($) employee	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring and severance				$ 23	$ 4,454
Restructuring Reserve [Roll Forward]
Income Statement Impact				23	4,454
2023 Reduction Action
Restructuring Cost and Reserve [Line Items]
Restructuring and severance				12
Restructuring Reserve [Roll Forward]
Accrued Balance at beginning of period				709
Income Statement Impact				12
Payments				(301)
Accrued Balance at end of period				420		$ 420
Q3 2023 action
Restructuring Cost and Reserve [Line Items]
Number of employee positions estimated to be eliminated in workforce reduction | employee			14
Restructuring and severance			$ 900
Restructuring Reserve [Roll Forward]
Income Statement Impact			900
Q2 2023 action
Restructuring Cost and Reserve [Line Items]
Number of employee positions estimated to be eliminated in workforce reduction | employee	197
Restructuring and severance	$ 2,100
Percentage of workforce eliminated						18%
Asset impairment charges					4,200
Intangible asset impairment charges					2,100
Property and equipment impairment charges					1,700
Operating lease right-of-use asset impairment charges					400
Restructuring Reserve [Roll Forward]
Income Statement Impact	$ 2,100
Q1 2023 action
Restructuring Cost and Reserve [Line Items]
Number of employee positions estimated to be eliminated in workforce reduction | employee		162
Restructuring and severance		$ 5,300			4,300
Restructuring Reserve [Roll Forward]
Income Statement Impact		5,300			$ 4,300
Q1 2023 action | Forecast
Restructuring Cost and Reserve [Line Items]
Percentage of workforce eliminated							13%
Employee separation payments | Q3 2023 action
Restructuring Cost and Reserve [Line Items]
Restructuring and severance			700	(7)
Restructuring Reserve [Roll Forward]
Accrued Balance at beginning of period				254
Income Statement Impact			700	(7)
Payments				(82)
Accrued Balance at end of period				165		$ 165
Employee separation payments | Q2 2023 action
Restructuring Cost and Reserve [Line Items]
Restructuring and severance				4
Restructuring Reserve [Roll Forward]
Accrued Balance at beginning of period				34
Income Statement Impact				4
Payments				(38)
Accrued Balance at end of period				0		0
Employee separation payments | Q1 2023 action
Restructuring Cost and Reserve [Line Items]
Restructuring and severance		4,300		15
Restructuring Reserve [Roll Forward]
Accrued Balance at beginning of period				421
Income Statement Impact		4,300		15
Payments				(181)
Accrued Balance at end of period				$ 255		$ 255
Non-cash compensation | Q3 2023 action
Restructuring Cost and Reserve [Line Items]
Restructuring and severance			200
Restructuring Reserve [Roll Forward]
Income Statement Impact			$ 200
Non-cash compensation | Q1 2023 action
Restructuring Cost and Reserve [Line Items]
Restructuring and severance		1,000
Restructuring Reserve [Roll Forward]
Income Statement Impact		$ 1,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Apr. 30, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 07, 2023	Mar. 08, 2023
Subsequent Event [Line Items]
Repayments of convertible debt		$ 0	$ 156,294
2025 Convertible Notes
Subsequent Event [Line Items]
Debt repurchase amount				$ 100,200	$ 190,600
2025 Convertible Notes | Convertible Debt | Subsequent Event
Subsequent Event [Line Items]
Debt repurchase amount	$ 37,700
Repayments of convertible debt	$ 35,300